世界のエンザルタミドAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Enzalutamide API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1137 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はエンザルタミドAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。エンザルタミドAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（エンザルタミドカプセル、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・エンザルタミドAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・エンザルタミドAPIの種類別市場規模：純度≥98％、純度<98％ ・エンザルタミドAPIの用途別市場規模：エンザルタミドカプセル、その他 ・北米のエンザルタミドAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのエンザルタミドAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのエンザルタミドAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のエンザルタミドAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのエンザルタミドAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Shilpa Medicare Limited、ScinoPharm Taiwan, Ltd、Olon Spa、Farmhispania, S.A.、Mac-Chem Products (India) Pvt.Ltd、Shandong Haohong Biotechnology ・エンザルタミドAPIのバリューチェーン・販売チャネル分析 ・エンザルタミドAPIの世界市場動向

Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.

Market Analysis and Insights: Global Enzalutamide API Market
The global Enzalutamide API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Enzalutamide API Scope and Segment
Enzalutamide API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Enzalutamide API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Enzalutamide Capsules Others By Company Dr. Reddy’s Laboratories Ltd. Shilpa Medicare Limited ScinoPharm Taiwan, Ltd Olon Spa Farmhispania, S.A. Mac-Chem Products (India) Pvt.Ltd Shandong Haohong Biotechnology Production by Region Europe China China Taiwan India Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Enzalutamide API Product Introduction
1.2 Market by Type
1.2.1 Global Enzalutamide API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Enzalutamide API Market Size Growth Rate by Application 1.3.2 Enzalutamide Capsules 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Enzalutamide API Production 2.1 Global Enzalutamide API Production Capacity (2016-2027) 2.2 Global Enzalutamide API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Enzalutamide API Production by Region 2.3.1 Global Enzalutamide API Historic Production by Region (2016-2021) 2.3.2 Global Enzalutamide API Forecasted Production by Region (2022-2027) 2.4 Europe 2.5 China 2.6 China Taiwan 2.7 India 3 Global Enzalutamide API Sales in Volume & Value Estimates and Forecasts 3.1 Global Enzalutamide API Sales Estimates and Forecasts 2016-2027 3.2 Global Enzalutamide API Revenue Estimates and Forecasts 2016-2027 3.3 Global Enzalutamide API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Enzalutamide API Regions by Sales 3.4.1 Global Top Enzalutamide API Regions by Sales (2016-2021) 3.4.2 Global Top Enzalutamide API Regions by Sales (2022-2027) 3.5 Global Top Enzalutamide API Regions by Revenue 3.5.1 Global Top Enzalutamide API Regions by Revenue (2016-2021) 3.5.2 Global Top Enzalutamide API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Enzalutamide API Production Capacity by Manufacturers 4.2 Global Enzalutamide API Sales by Manufacturers 4.2.1 Global Top Enzalutamide API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Enzalutamide API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Enzalutamide API Sales in 2020 4.3 Global Enzalutamide API Revenue by Manufacturers 4.3.1 Global Top Enzalutamide API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Enzalutamide API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Enzalutamide API Revenue in 2020 4.4 Global Enzalutamide API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Enzalutamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Enzalutamide API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Enzalutamide API Sales by Type 5.1.1 Global Enzalutamide API Historical Sales by Type (2016-2021) 5.1.2 Global Enzalutamide API Forecasted Sales by Type (2022-2027) 5.1.3 Global Enzalutamide API Sales Market Share by Type (2016-2027) 5.2 Global Enzalutamide API Revenue by Type 5.2.1 Global Enzalutamide API Historical Revenue by Type (2016-2021) 5.2.2 Global Enzalutamide API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Enzalutamide API Revenue Market Share by Type (2016-2027) 5.3 Global Enzalutamide API Price by Type 5.3.1 Global Enzalutamide API Price by Type (2016-2021) 5.3.2 Global Enzalutamide API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Enzalutamide API Sales by Application 6.1.1 Global Enzalutamide API Historical Sales by Application (2016-2021) 6.1.2 Global Enzalutamide API Forecasted Sales by Application (2022-2027) 6.1.3 Global Enzalutamide API Sales Market Share by Application (2016-2027) 6.2 Global Enzalutamide API Revenue by Application 6.2.1 Global Enzalutamide API Historical Revenue by Application (2016-2021) 6.2.2 Global Enzalutamide API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Enzalutamide API Revenue Market Share by Application (2016-2027) 6.3 Global Enzalutamide API Price by Application 6.3.1 Global Enzalutamide API Price by Application (2016-2021) 6.3.2 Global Enzalutamide API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Enzalutamide API Market Size by Type 7.1.1 North America Enzalutamide API Sales by Type (2016-2027) 7.1.2 North America Enzalutamide API Revenue by Type (2016-2027) 7.2 North America Enzalutamide API Market Size by Application 7.2.1 North America Enzalutamide API Sales by Application (2016-2027) 7.2.2 North America Enzalutamide API Revenue by Application (2016-2027) 7.3 North America Enzalutamide API Sales by Country 7.3.1 North America Enzalutamide API Sales by Country (2016-2027) 7.3.2 North America Enzalutamide API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Enzalutamide API Market Size by Type 8.1.1 Europe Enzalutamide API Sales by Type (2016-2027) 8.1.2 Europe Enzalutamide API Revenue by Type (2016-2027) 8.2 Europe Enzalutamide API Market Size by Application 8.2.1 Europe Enzalutamide API Sales by Application (2016-2027) 8.2.2 Europe Enzalutamide API Revenue by Application (2016-2027) 8.3 Europe Enzalutamide API Sales by Country 8.3.1 Europe Enzalutamide API Sales by Country (2016-2027) 8.3.2 Europe Enzalutamide API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Enzalutamide API Market Size by Type 9.1.1 Asia Pacific Enzalutamide API Sales by Type (2016-2027) 9.1.2 Asia Pacific Enzalutamide API Revenue by Type (2016-2027) 9.2 Asia Pacific Enzalutamide API Market Size by Application 9.2.1 Asia Pacific Enzalutamide API Sales by Application (2016-2027) 9.2.2 Asia Pacific Enzalutamide API Revenue by Application (2016-2027) 9.3 Asia Pacific Enzalutamide API Sales by Region 9.3.1 Asia Pacific Enzalutamide API Sales by Region (2016-2027) 9.3.2 Asia Pacific Enzalutamide API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Enzalutamide API Market Size by Type 10.1.1 Latin America Enzalutamide API Sales by Type (2016-2027) 10.1.2 Latin America Enzalutamide API Revenue by Type (2016-2027) 10.2 Latin America Enzalutamide API Market Size by Application 10.2.1 Latin America Enzalutamide API Sales by Application (2016-2027) 10.2.2 Latin America Enzalutamide API Revenue by Application (2016-2027) 10.3 Latin America Enzalutamide API Sales by Country 10.3.1 Latin America Enzalutamide API Sales by Country (2016-2027) 10.3.2 Latin America Enzalutamide API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Enzalutamide API Market Size by Type 11.1.1 Middle East and Africa Enzalutamide API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Enzalutamide API Revenue by Type (2016-2027) 11.2 Middle East and Africa Enzalutamide API Market Size by Application 11.2.1 Middle East and Africa Enzalutamide API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Enzalutamide API Revenue by Application (2016-2027) 11.3 Middle East and Africa Enzalutamide API Sales by Country 11.3.1 Middle East and Africa Enzalutamide API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Enzalutamide API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Shilpa Medicare Limited 12.2.1 Shilpa Medicare Limited Corporation Information 12.2.2 Shilpa Medicare Limited Overview 12.2.3 Shilpa Medicare Limited Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Shilpa Medicare Limited Enzalutamide API Product Description 12.2.5 Shilpa Medicare Limited Recent Developments 12.3 ScinoPharm Taiwan, Ltd 12.3.1 ScinoPharm Taiwan, Ltd Corporation Information 12.3.2 ScinoPharm Taiwan, Ltd Overview 12.3.3 ScinoPharm Taiwan, Ltd Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 ScinoPharm Taiwan, Ltd Enzalutamide API Product Description 12.3.5 ScinoPharm Taiwan, Ltd Recent Developments 12.4 Olon Spa 12.4.1 Olon Spa Corporation Information 12.4.2 Olon Spa Overview 12.4.3 Olon Spa Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Olon Spa Enzalutamide API Product Description 12.4.5 Olon Spa Recent Developments 12.5 Farmhispania, S.A. 12.5.1 Farmhispania, S.A. Corporation Information 12.5.2 Farmhispania, S.A. Overview 12.5.3 Farmhispania, S.A. Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Farmhispania, S.A. Enzalutamide API Product Description 12.5.5 Farmhispania, S.A. Recent Developments 12.6 Mac-Chem Products (India) Pvt.Ltd 12.6.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information 12.6.2 Mac-Chem Products (India) Pvt.Ltd Overview 12.6.3 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Description 12.6.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments 12.7 Shandong Haohong Biotechnology 12.7.1 Shandong Haohong Biotechnology Corporation Information 12.7.2 Shandong Haohong Biotechnology Overview 12.7.3 Shandong Haohong Biotechnology Enzalutamide API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Shandong Haohong Biotechnology Enzalutamide API Product Description 12.7.5 Shandong Haohong Biotechnology Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Enzalutamide API Industry Chain Analysis 13.2 Enzalutamide API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Enzalutamide API Production Mode & Process 13.4 Enzalutamide API Sales and Marketing 13.4.1 Enzalutamide API Sales Channels 13.4.2 Enzalutamide API Distributors 13.5 Enzalutamide API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Enzalutamide API Industry Trends 14.2 Enzalutamide API Market Drivers 14.3 Enzalutamide API Market Challenges 14.4 Enzalutamide API Market Restraints 15 Key Finding in The Global Enzalutamide API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Enzalutamide API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Enzalutamide API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Enzalutamide API Production by Region: 2016 VS 2021 VS 2027 (Kiloton)
Table 6. Global Enzalutamide API Production by Region (2016-2021) & (Kiloton)
Table 7. Global Enzalutamide API Production Market Share by Region (2016-2021)
Table 8. Global Enzalutamide API Production by Region (2022-2027) & (Kiloton)
Table 9. Global Enzalutamide API Production Market Share by Region (2022-2027)
Table 10. Global Enzalutamide API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Enzalutamide API Sales by Region (2016-2021) & (Kiloton)
Table 12. Global Enzalutamide API Sales Market Share by Region (2016-2021)
Table 13. Global Enzalutamide API Sales by Region (2022-2027) & (Kiloton)
Table 14. Global Enzalutamide API Sales Market Share by Region (2022-2027)
Table 15. Global Enzalutamide API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Enzalutamide API Revenue Market Share by Region (2016-2021)
Table 17. Global Enzalutamide API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Enzalutamide API Revenue Market Share by Region (2022-2027)
Table 19. Global Enzalutamide API Production Capacity by Manufacturers (2016-2021) & (Kiloton)
Table 20. Global Enzalutamide API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Enzalutamide API Production by Manufacturers (2016-2021) & (Kiloton)
Table 22. Global Enzalutamide API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Enzalutamide API Sales by Manufacturers (2016-2021) & (Kiloton)
Table 24. Global Enzalutamide API Sales Share by Manufacturers (2016-2021)
Table 25. Global Enzalutamide API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Enzalutamide API Revenue Share by Manufacturers (2016-2021)
Table 27. Enzalutamide API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Enzalutamide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Enzalutamide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide API as of 2020)
Table 30. Enzalutamide API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Enzalutamide API Product Offered
Table 32. Date of Manufacturers Enter into Enzalutamide API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Enzalutamide API Sales by Type (2016-2021) & (Kiloton)
Table 35. Global Enzalutamide API Sales by Type (2022-2027) & (Kiloton)
Table 36. Global Enzalutamide API Sales Share by Type (2016-2021)
Table 37. Global Enzalutamide API Sales Share by Type (2022-2027)
Table 38. Global Enzalutamide API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Enzalutamide API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Enzalutamide API Revenue Share by Type (2016-2021)
Table 41. Global Enzalutamide API Revenue Share by Type (2022-2027)
Table 42. Enzalutamide API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Enzalutamide API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Enzalutamide API Sales by Application (2016-2021) & (Kiloton)
Table 45. Global Enzalutamide API Sales by Application (2022-2027) & (Kiloton)
Table 46. Global Enzalutamide API Sales Share by Application (2016-2021)
Table 47. Global Enzalutamide API Sales Share by Application (2022-2027)
Table 48. Global Enzalutamide API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Enzalutamide API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Enzalutamide API Revenue Share by Application (2016-2021)
Table 51. Global Enzalutamide API Revenue Share by Application (2022-2027)
Table 52. Enzalutamide API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Enzalutamide API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Enzalutamide API Sales by Type (2016-2021) & (Kiloton)
Table 55. North America Enzalutamide API Sales by Type (2022-2027) & (Kiloton)
Table 56. North America Enzalutamide API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Enzalutamide API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Enzalutamide API Sales by Application (2016-2021) & (Kiloton)
Table 59. North America Enzalutamide API Sales by Application (2022-2027) & (Kiloton)
Table 60. North America Enzalutamide API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Enzalutamide API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Enzalutamide API Sales by Country (2016-2021) & (Kiloton)
Table 63. North America Enzalutamide API Sales by Country (2022-2027) & (Kiloton)
Table 64. North America Enzalutamide API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Enzalutamide API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Enzalutamide API Sales by Type (2016-2021) & (Kiloton)
Table 67. Europe Enzalutamide API Sales by Type (2022-2027) & (Kiloton)
Table 68. Europe Enzalutamide API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Enzalutamide API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Enzalutamide API Sales by Application (2016-2021) & (Kiloton)
Table 71. Europe Enzalutamide API Sales by Application (2022-2027) & (Kiloton)
Table 72. Europe Enzalutamide API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Enzalutamide API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Enzalutamide API Sales by Country (2016-2021) & (Kiloton)
Table 75. Europe Enzalutamide API Sales by Country (2022-2027) & (Kiloton)
Table 76. Europe Enzalutamide API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Enzalutamide API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Enzalutamide API Sales by Type (2016-2021) & (Kiloton)
Table 79. Asia Pacific Enzalutamide API Sales by Type (2022-2027) & (Kiloton)
Table 80. Asia Pacific Enzalutamide API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Enzalutamide API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Enzalutamide API Sales by Application (2016-2021) & (Kiloton)
Table 83. Asia Pacific Enzalutamide API Sales by Application (2022-2027) & (Kiloton)
Table 84. Asia Pacific Enzalutamide API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Enzalutamide API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Enzalutamide API Sales by Region (2016-2021) & (Kiloton)
Table 87. Asia Pacific Enzalutamide API Sales by Region (2022-2027) & (Kiloton)
Table 88. Asia Pacific Enzalutamide API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Enzalutamide API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Enzalutamide API Sales by Type (2016-2021) & (Kiloton)
Table 91. Latin America Enzalutamide API Sales by Type (2022-2027) & (Kiloton)
Table 92. Latin America Enzalutamide API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Enzalutamide API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Enzalutamide API Sales by Application (2016-2021) & (Kiloton)
Table 95. Latin America Enzalutamide API Sales by Application (2022-2027) & (Kiloton)
Table 96. Latin America Enzalutamide API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Enzalutamide API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Enzalutamide API Sales by Country (2016-2021) & (Kiloton)
Table 99. Latin America Enzalutamide API Sales by Country (2022-2027) & (Kiloton)
Table 100. Latin America Enzalutamide API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Enzalutamide API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Enzalutamide API Sales by Type (2016-2021) & (Kiloton)
Table 103. Middle East and Africa Enzalutamide API Sales by Type (2022-2027) & (Kiloton)
Table 104. Middle East and Africa Enzalutamide API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Enzalutamide API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Enzalutamide API Sales by Application (2016-2021) & (Kiloton)
Table 107. Middle East and Africa Enzalutamide API Sales by Application (2022-2027) & (Kiloton)
Table 108. Middle East and Africa Enzalutamide API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Enzalutamide API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Enzalutamide API Sales by Country (2016-2021) & (Kiloton)
Table 111. Middle East and Africa Enzalutamide API Sales by Country (2022-2027) & (Kiloton)
Table 112. Middle East and Africa Enzalutamide API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Enzalutamide API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Shilpa Medicare Limited Corporation Information
Table 120. Shilpa Medicare Limited Description and Major Businesses
Table 121. Shilpa Medicare Limited Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Shilpa Medicare Limited Enzalutamide API Product
Table 123. Shilpa Medicare Limited Recent Development
Table 124. ScinoPharm Taiwan, Ltd Corporation Information
Table 125. ScinoPharm Taiwan, Ltd Description and Major Businesses
Table 126. ScinoPharm Taiwan, Ltd Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. ScinoPharm Taiwan, Ltd Enzalutamide API Product
Table 128. ScinoPharm Taiwan, Ltd Recent Development
Table 129. Olon Spa Corporation Information
Table 130. Olon Spa Description and Major Businesses
Table 131. Olon Spa Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Olon Spa Enzalutamide API Product
Table 133. Olon Spa Recent Development
Table 134. Farmhispania, S.A. Corporation Information
Table 135. Farmhispania, S.A. Description and Major Businesses
Table 136. Farmhispania, S.A. Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Farmhispania, S.A. Enzalutamide API Product
Table 138. Farmhispania, S.A. Recent Development
Table 139. Mac-Chem Products (India) Pvt.Ltd Corporation Information
Table 140. Mac-Chem Products (India) Pvt.Ltd Description and Major Businesses
Table 141. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product
Table 143. Mac-Chem Products (India) Pvt.Ltd Recent Development
Table 144. Shandong Haohong Biotechnology Corporation Information
Table 145. Shandong Haohong Biotechnology Description and Major Businesses
Table 146. Shandong Haohong Biotechnology Enzalutamide API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Shandong Haohong Biotechnology Enzalutamide API Product
Table 148. Shandong Haohong Biotechnology Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Enzalutamide API Distributors List
Table 152. Enzalutamide API Customers List
Table 153. Enzalutamide API Market Trends
Table 154. Enzalutamide API Market Drivers
Table 155. Enzalutamide API Market Challenges
Table 156. Enzalutamide API Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Enzalutamide API Product Picture
Figure 2. Global Enzalutamide API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Enzalutamide API Market Share by Application in 2020 & 2027
Figure 6. Enzalutamide Capsules
Figure 7. Others
Figure 8. Enzalutamide API Report Years Considered
Figure 9. Global Enzalutamide API Capacity, Production and Utilization (2016-2027) & (Kiloton)
Figure 10. Global Enzalutamide API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Enzalutamide API Production Market Share by Region (2016-2021)
Figure 12. Global Enzalutamide API Production Market Share by Region (2022-2027)
Figure 13. Enzalutamide API Production Growth Rate in Europe (2016-2027) & (Kiloton)
Figure 14. Enzalutamide API Production Growth Rate in China (2016-2027) & (Kiloton)
Figure 15. Enzalutamide API Production Growth Rate in China Taiwan (2016-2027) & (Kiloton)
Figure 16. Enzalutamide API Production Growth Rate in India (2016-2027) & (Kiloton)
Figure 17. Global Enzalutamide API Sales 2016-2027 (Kiloton)
Figure 18. Global Enzalutamide API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Enzalutamide API Revenue 2016-2027 (US$ Million)
Figure 20. Global Enzalutamide API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Enzalutamide API Sales Market Share by Region (2016-2021)
Figure 22. Global Enzalutamide API Sales Market Share by Region (2022-2027)
Figure 23. North America Enzalutamide API Sales YoY (2016-2027) & (Kiloton)
Figure 24. North America Enzalutamide API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Enzalutamide API Sales YoY (2016-2027) & (Kiloton)
Figure 26. Europe Enzalutamide API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Enzalutamide API Sales YoY (2016-2027) & (Kiloton)
Figure 28. Asia-Pacific Enzalutamide API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Enzalutamide API Sales YoY (2016-2027) & (Kiloton)
Figure 30. Latin America Enzalutamide API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Enzalutamide API Sales YoY (2016-2027) & (Kiloton)
Figure 32. Middle East & Africa Enzalutamide API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Enzalutamide API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Enzalutamide API Revenue in 2020
Figure 35. Enzalutamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Enzalutamide API Sales Market Share by Type (2016-2027)
Figure 37. Global Enzalutamide API Revenue Market Share by Type (2016-2027)
Figure 38. Global Enzalutamide API Sales Market Share by Application (2016-2027)
Figure 39. Global Enzalutamide API Revenue Market Share by Application (2016-2027)
Figure 40. North America Enzalutamide API Sales Market Share by Type (2016-2027)
Figure 41. North America Enzalutamide API Revenue Market Share by Type (2016-2027)
Figure 42. North America Enzalutamide API Sales Market Share by Application (2016-2027)
Figure 43. North America Enzalutamide API Revenue Market Share by Application (2016-2027)
Figure 44. North America Enzalutamide API Sales Share by Country (2016-2027)
Figure 45. North America Enzalutamide API Revenue Share by Country (2016-2027)
Figure 46. United States Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Enzalutamide API Sales Market Share by Type (2016-2027)
Figure 49. Europe Enzalutamide API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Enzalutamide API Sales Market Share by Application (2016-2027)
Figure 51. Europe Enzalutamide API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Enzalutamide API Sales Share by Country (2016-2027)
Figure 53. Europe Enzalutamide API Revenue Share by Country (2016-2027)
Figure 54. Germany Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 55. France Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Enzalutamide API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Enzalutamide API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Enzalutamide API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Enzalutamide API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Enzalutamide API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Enzalutamide API Revenue Share by Region (2016-2027)
Figure 65. China Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 68. India Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Enzalutamide API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Enzalutamide API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Enzalutamide API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Enzalutamide API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Enzalutamide API Sales Share by Country (2016-2027)
Figure 79. Latin America Enzalutamide API Revenue Share by Country (2016-2027)
Figure 80. Mexico Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Enzalutamide API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Enzalutamide API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Enzalutamide API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Enzalutamide API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Enzalutamide API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Enzalutamide API Revenue Share by Country (2016-2027)
Figure 89. Turkey Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Enzalutamide API Revenue (2016-2027) & (US$ Million)
Figure 92. Enzalutamide API Value Chain
Figure 93. Enzalutamide API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---